Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Fluorescent H3 antagonist [clobenpropit] (AC127)
Cat.#: ASSD-127
Specifications
Description Fluorescent H3 histamine receptor antagonist (apparent KD values are 7.09, 6.55 and 5.71 for H3, H1 and H2 receptors respectively). Also antagonizes the activity of Histamine, a H1 agonist. Displays no intrinsic activity. Size 50 μg Applications For imaging at H3, H2 and H1 receptors use solutions up to 100 nM. Molecule Weight 848.5 Purity >95% Solubility Soluble in DMSO Excitation 633 nm Emission 650 nm Storage Store at -20° C Shipping Shipped at 4°C Important We strongly recommend storing this product away from light and briefly sonicating the sample when using to ensure it is fully dissolved and the solution is homogeneous. However, we do not recommend using the product after subjecting it to repetitive freeze-thaw cycles. Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ASSD-116 Annexin V-FITC Apoptosis Staining / Detection Kit (AC116) 1 kit, 100 tests inquiry ASSD-176 Rhodamine B isothiocyanate (AC176) 100 mg, 500 mg inquiry ASSD-114 Acridine Orange hydrochloride (AC114) 50 mg inquiry ASSD-110 Picro Sirius Red Stain Kit (AC110) 1 kit, 100 tests inquiry ASSD-140 A2B covalent ligand (AC140) 50 μg inquiry ASSD-167 Fura-2 AM (Cell permeant) (AC167) 1 mg inquiry ASSD-181 Nitrofluorescein, Isomer 1 (AC181) 1 g inquiry ASSD-107 Modified Mayer's Hematoxylin (AC107) 125 mL, 250 mL, 2×250mL inquiry ASSD-177 Fluorescein 5-Maleimide (AC177) 25 mg inquiry ASSD-172 Ionomycin free acid (AC172) 1mg, 5mg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket